Keywords: Novo Nordisk, Victoza, Blood sugar control, Weight reduction, Label change, USA, Type 2 diabetes, Levemir, Merck & Co, Januvia
Victoza US label update includes superior efficacy over Januvia, says Novo Nordisk
Article | 10 April 2012
The US Food and Drug Administration has approved an update to the product label for Victoza (liraglutide [rDNA] injection), from ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
